Giacomo Drago

Giam Pharma International is an emerging pharmaceutical company focused on the discovery and development of next-generation therapeutics in oncology and rare diseases.

We combine scientific excellence with strategic agility to accelerate the transition from laboratory innovation to clinical application. Our core expertise lies in target identification, small-molecule design, and translational research, with a strong commitment to delivering high-impact treatments for patients with unmet medical needs.

Giam Pharma operates at the intersection of academic research and biotech entrepreneurship. We collaborate with leading research institutions, CROs, and strategic partners to drive preclinical validation, regulatory planning, and early-stage clinical development.